Cargando…

3,4-Methylenedioxymethamphetamine (MDMA)-Assisted Therapy in Hawaii: A Brief Review

The Food and Drug Administration (FDA) granted breakthrough therapy status to 3,4-methylenedioxymethamphetamine-assisted therapy (MDMA-AT) in 2017 due to preliminary evidence supporting its efficacy and safety in treating post-traumatic stress disorder (PTSD). A series of six phase-II clinical tri...

Descripción completa

Detalles Bibliográficos
Autores principales:	Inouye, Ann, Wolfgang, Aaron
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Cureus 2022
Materias:	Psychiatry
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9337778/ https://www.ncbi.nlm.nih.gov/pubmed/35915689 http://dx.doi.org/10.7759/cureus.26402

Ejemplares similares

A Review of 3,4-methylenedioxymethamphetamine (MDMA)-Assisted Psychotherapy
por: Sessa, Ben, et al.
Publicado: (2019)

3,4-methylenedioxymethamphetamine (MDMA): current perspectives
por: Meyer, Jerrold S
Publicado: (2013)

A review on the mitochondrial toxicity of “ecstasy” (3,4-methylenedioxymethamphetamine, MDMA)
por: Capela, João Paulo, et al.
Publicado: (2022)

Effects of (±) 3,4-Methylenedioxymethamphetamine (MDMA) on Sleep and Circadian Rhythms
por: McCann, Una D., et al.
Publicado: (2007)

Social Cognition and Interaction in Chronic Users of 3,4-Methylenedioxymethamphetamine (MDMA, “Ecstasy”)
por: Wunderli, Michael D, et al.
Publicado: (2017)

MDMA (3,4-Methylenedioxymethamphetamine) Analogues as Tools to Characterize MDMA-Like Effects: An Approach to Understand Entactogen Pharmacology
por: Sáez-Briones, P., et al.
Publicado: (2013)

3,4-Methylenedioxymethamphetamine (MDMA) neurotoxicity in rats: a reappraisal of past and present findings
por: Baumann, Michael H., et al.
Publicado: (2006)

The influence of the host microbiome on 3,4-methylenedioxymethamphetamine (MDMA)-induced hyperthermia and vice versa
por: Ridge, Emily A., et al.
Publicado: (2019)

Effects of Repeated Administration of 3,4-methylenedioxymethamphetamine (MDMA) on Avoidance Memory and Cell Density in Rats’ Hippocampus
por: Jahanshahi, Mehrdad, et al.
Publicado: (2013)

Additive Effects of 3,4-Methylenedioxymethamphetamine (MDMA) and Compassionate Imagery on Self-Compassion in Recreational Users of Ecstasy
por: Kamboj, Sunjeev K., et al.
Publicado: (2017)

Cardiac effects of ephedrine, norephedrine, mescaline, and 3,4-methylenedioxymethamphetamine (MDMA) in mouse and human atrial preparations
por: Neumann, Joachim, et al.
Publicado: (2022)

Chronic 3,4-Methylenedioxymethamphetamine (MDMA) Use Is Related to Glutamate and GABA Concentrations in the Striatum But Not the Anterior Cingulate Cortex
por: Zimmermann, Josua, et al.
Publicado: (2023)

The Efficacy of MDMA (3,4-Methylenedioxymethamphetamine) for Post-traumatic Stress Disorder in Humans: A Systematic Review and Meta-Analysis
por: Tedesco, Sarah, et al.
Publicado: (2021)

Methylenedioxymethamphetamine (MDMA, ‘Ecstasy’): Neurodegeneration versus Neuromodulation
por: Puerta, Elena, et al.
Publicado: (2011)

Detection of acute 3,4-methylenedioxymethamphetamine (MDMA) effects across protocols using automated natural language processing
por: Agurto, Carla, et al.
Publicado: (2020)

Differential sensitivity to detect prosocial effects of 3,4‐methylenedioxymethamphetamine (MDMA) in different social approach paradigms in mice
por: Mukai, Satoko, et al.
Publicado: (2020)

Methylenedioxymethamphetamine (MDMA)-Induced Hyponatremia: Case Report and Literature Review
por: Elkattawy, Sherif, et al.
Publicado: (2021)

Acute effects of MDMA (3,4-methylenedioxymethamphetamine) on EEG oscillations: alone and in combination with ethanol or THC (delta-9-tetrahydrocannabinol)
por: Lansbergen, Marieke M., et al.
Publicado: (2010)

Pentoxifylline Protects the Rat Liver Against Fibrosis and Apoptosis Induced by Acute Administration of 3,4-Methylenedioxymethamphetamine (MDMA or Ecstasy)
por: Movassaghi, Shabnam, et al.
Publicado: (2013)

3,4-methylenedioxymethamphetamine (MDMA)-assisted psychotherapy for victims of sexual abuse with severe post-traumatic stress disorder: an open label pilot study in Brazil
por: Jardim, Alvaro V., et al.
Publicado: (2020)

Changes in interleukin-1 signal modulators induced by 3,4-methylenedioxymethamphetamine (MDMA): regulation by CB2 receptors and implications for neurotoxicity
por: Torres, Elisa, et al.
Publicado: (2011)

A proposed mechanism for the MDMA-mediated extinction of traumatic memories in PTSD patients treated with MDMA-assisted therapy
por: Sottile, Robert J., et al.
Publicado: (2022)

Clinical Pharmacology of 3,4-Methylenedioxymethamphetamine (MDMA, “Ecstasy”): The Influence of Gender and Genetics (CYP2D6, COMT, 5-HTT)
por: Pardo-Lozano, Ricardo, et al.
Publicado: (2012)

The Nature of 3, 4-Methylenedioxymethamphetamine (MDMA)-Induced Serotonergic Dysfunction: Evidence for and Against the Neurodegeneration Hypothesis
por: Biezonski, Dominik K, et al.
Publicado: (2011)

A High-Resolution Magic Angle Spinning NMR Study of the Enantiodiscrimination of 3,4-Methylenedioxymethamphetamine (MDMA) by an Immobilized Polysaccharide-Based Chiral Phase
por: Barreiro, Juliana C., et al.
Publicado: (2016)

Amitriptyline Accelerates SERT Binding Recovery in a Rat 3,4-Methylenedioxymethamphetamine (MDMA) Model: In Vivo 4-[(18)F]-ADAM PET Imaging
por: Tsai, Chi-Jung, et al.
Publicado: (2022)

3,4-Methylenedioxymethamphetamine facilitates fear extinction learning
por: Young, M B, et al.
Publicado: (2015)

Therapeutic setting as an essential component of psychedelic research methodology: Reporting recommendations emerging from clinical trials of 3,4-methylenedioxymethamphetamine for post-traumatic stress disorder
por: Okano, Lauren, et al.
Publicado: (2022)

Effects of 3,4-Methylenedioxymethamphetamine Administration on Retinal Physiology in the Rat
por: Martins, João, et al.
Publicado: (2011)

The Effects of 3,4-methylenedioxymethamphetamine on Neurogenesis in the Hippocampus of Male Rats
por: Soleimani Asl, Sara, et al.
Publicado: (2020)

Social anxiety and MDMA-assisted therapy investigation: a novel clinical trial protocol
por: Lear, M. Kati, et al.
Publicado: (2023)

Therapeutic role of psilocybin and 3,4-methylenedioxymethamphetamine in trauma: A literature review
por: Fonseka, Lakshan N, et al.
Publicado: (2023)

Relational and Growth Outcomes Following Couples Therapy With MDMA for PTSD
por: Wagner, Anne C., et al.
Publicado: (2021)

Neuronal reorganization in adult rats neonatally exposed to (±)-3,4-methylenedioxymethamphetamine
por: Williams, Michael T., et al.
Publicado: (2014)

The Non-Peptide Arginine-Vasopressin v(1a) Selective Receptor Antagonist, SR49059, Blocks the Rewarding, Prosocial, and Anxiolytic Effects of 3,4-Methylenedioxymethamphetamine and Its Derivatives in Zebra Fish
por: Ponzoni, Luisa, et al.
Publicado: (2017)

Altered brain activity and functional connectivity after MDMA-assisted therapy for post-traumatic stress disorder
por: Singleton, S. Parker, et al.
Publicado: (2023)

Impact of Cytochrome P450 2D6 Function on the Chiral Blood Plasma Pharmacokinetics of 3,4-Methylenedioxymethamphetamine (MDMA) and Its Phase I and II Metabolites in Humans
por: Steuer, Andrea E., et al.
Publicado: (2016)

Study protocol for “MDMA-assisted therapy as a treatment for major depressive disorder: A proof of principle study”
por: Kvam, Tor-Morten, et al.
Publicado: (2022)

MDMA-assisted therapy is associated with a reduction in chronic pain among people with post-traumatic stress disorder
por: Christie, Devon, et al.
Publicado: (2022)

Brain-derived neurotrophic factor protects serotonergic neurons against 3,4-methylenedioxymethamphetamine (“Ecstasy”) induced cytoskeletal damage
por: Bavato, F., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_7rkh21nvmq5hi3nkdqhnpa0qa0